Two Sigma Securities’s BioNTech BNTX Stock Holding History

Two Sigma Securities’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,200	Closed	-$1.92M	–	1794
2024 Q3	$1.92M	Buy	+16,200	New	+$1.49M	0.03%	562
2024 Q2	–	Sell	-10,300	Closed	-$950K	–	3006
2024 Q1	$950K	Sell	10,300 -4,500	-30%	-$431K	0.01%	1160
2023 Q4	$1.56M	Buy	14,800 +9,400	+174%	+$947K	0.02%	814
2023 Q3	$587K	Sell	5,400 -2,700	-33%	-$299K	0.01%	1417
2023 Q2	$874K	Sell	8,100 -12,100	-60%	-$1.36M	0.01%	1051
2023 Q1	$2.52M	Buy	+20,200	New	+$2.77M	0.05%	442
2022 Q4	–	Sell	-10,400	Closed	-$1.4M	–	2613
2022 Q3	$1.4M	Hold	10,400	–	–	0.04%	495
2022 Q2	$1.55M	Sell	10,400 -14,400	-58%	-$2.2M	0.06%	376
2022 Q1	$4.23M	Buy	24,800 +23,300	+1,553%	+$3.92M	0.15%	158
2021 Q4	$387K	Sell	1,500 -10,800	-88%	-$2.96M	0.02%	668
2021 Q3	$3.36M	Buy	12,300 +9,400	+324%	+$2.99M	0.1%	183
2021 Q2	$649K	Buy	+2,900	New	+$547K	0.02%	539

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Securities's BNTX Position: Q1 2026 in Review

Two Sigma Securities sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 8,052 shares — an estimated $767K sold.

Two Sigma Securities first reported a position in BNTX in Q4 2020 and held it in 12 quarters. The position peaked at $6.14M in Q3 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Two Sigma Securities reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 8,052 BioNTech shares in Q1 2026, an estimated $767K.
Two Sigma Securities first reported a position in BioNTech in Q4 2020 and held it in 12 quarters.
Two Sigma Securities's BioNTech position peaked at $6.14M in Q3 2024.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.